Active Ingredient(s): Emtricitabine + Rilpivirine + Tenofovir Alafenamide
FDA Approved: * March 1, 2016
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Odefsey Overview

Tenofovir alafenamide, sold under the brand name Vemlidy, is a hepatitis B virus (HBV) nucleotide reverse transcriptase inhibitor medication for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease.[3] It is taken by mouth.[3] Tenofovir alafenamide is a prodrug of tenofovir. It was developed by Gilead Sciences based on the protide technology of Chris McGuigan for use in the treatment of HIV/AIDS and chronic hepatit...

Read more Odefsey Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tenofovir_alafenamide

Recent Odefsey Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Emtricitabine + Rilpivirine + Tenofovir Alafenamide
  • Tablet: 200 + 25 + 25mg, 200mg + 25mg + 25mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Odefsey: (3 results)

Sorted by National Drug Code
  • 50090-2340 Odefsey Oral Tablet by A-s Medication Solutions
  • 61958-2101 Odefsey Oral Tablet by Gilead Sciences, Inc.
  • 70518-0695 Odefsey Oral Tablet by Remedyrepack Inc.

Drugs with one or more similar ingredients: (24 results)